Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: TOPFUEL who wrote (2444)	7/2/1998 2:30:00 PM
From: Turboe	Read Replies (1) \| Respond to of 5402

I-95 closed... The state is on fire...

To: TOPFUEL who wrote (2444)	7/12/1998 1:42:00 PM
From: Prospector	Respond to of 5402

Heart attack::: Methods are being sought to reduce the damage to the heart muscle caused by heart attack. Due to the small size of the perflurocarbon molecule in PHER-02, it can bypass the blockage and perfuse the myocardium. This will allow the infarction to be treated in the home or ambulance, rather that waiting for arrival at the hospital and up to two-hour delays to type and cross-match the donor blood. There are approximately 6,000,000 heart attacks per year in the industrialized world. Stroke:::: The same treatment used for heart attack can be used for oxygen deprivation in the brain caused by stroke. PHER-02 can be infused in the bed or ambulance to enrich the oxygen-starved brain. Prospector